awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34207379-1E7003FA-5D5C-4274-AC57-8D70B21F5850
Q34207379-1E7003FA-5D5C-4274-AC57-8D70B21F5850
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34207379-1E7003FA-5D5C-4274-AC57-8D70B21F5850
Is there something other than imatinib mesilate in therapeutic options for GIST?
P2860
Q34207379-1E7003FA-5D5C-4274-AC57-8D70B21F5850
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34207379-1E7003FA-5D5C-4274-AC57-8D70B21F5850
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4ab1f96e17fcafc6f316ba5f91607642bed1d71b
P2860
Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group.